Senti Biosciences, Inc. - SNTI Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of sentibio.com (SNTI)

The LTM sales growth YoY metric demonstrates the impact of early-stage clinical trials on liquidity, where the 0.00 mark records this figure. Senti Biosciences, Inc. (SNTI) minimizes risks by utilizing AI to develop gene circuits targeting liver and blood cancers. This results in a unique biotechnological environment with a protected patent portfolio, creating high value for strategic partners.

Senti Biosciences (SNTI): Sales Growth YoY (TTM) from 02/11/2024 to 11/17/2026

Senti Biosciences (SNTI) - metric breakdowns and financial figures

- stock price and consensus target price:
Fundamental company valuation:Senti Bio
Flagship merchandise of sentibio.com

Operational business quality is determined by the ability to generate a sustainable cash flow. This indicator measures the revenue growth rate over a rolling year, neutralizing seasonality and revealing the company's actual expansion speed. This is critical for Senti Biosciences, Inc. (SNTI), as geopolitical barriers hinder the cross-border logistics of biomaterials. By analyzing the year-over-year sales dynamics over the last 12 months TTM, an investor will notice hidden inflection points in the development of gene therapy.